These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25252675)

  • 1. [Peripheral nervous system and speech disorders].
    Ferri L
    Rev Neurol; 2014 Feb; 58 Suppl 1():S99-S105. PubMed ID: 25252675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-speech oro-motor exercise use in acquired dysarthria management: regimes and rationales.
    Mackenzie C; Muir M; Allen C
    Int J Lang Commun Disord; 2010; 45(6):617-29. PubMed ID: 20085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysarthria of motor neuron disease: longitudinal measures of segmental durations.
    Seikel JA; Wilcox KA; Davis J
    J Commun Disord; 1991; 24(5-6):393-409. PubMed ID: 1809779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptual evaluation of motor speech following treatment for childhood cerebellar tumour.
    Cornwell PL; Murdoch BE; Ward EC; Kellie S
    Clin Linguist Phon; 2003 Dec; 17(8):597-615. PubMed ID: 14977025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the needs of speakers with longstanding dysarthria: computerized and traditional therapy compared.
    Palmer R; Enderby P; Hawley M
    Int J Lang Commun Disord; 2007 Mar; 42 Suppl 1():61-79. PubMed ID: 17454237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left-hemispheric dominance for articulation: a prospective study on acute ischaemic dysarthria at different localizations.
    Urban PP; Rolke R; Wicht S; Keilmann A; Stoeter P; Hopf HC; Dieterich M
    Brain; 2006 Mar; 129(Pt 3):767-77. PubMed ID: 16418180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromotor speech impairment: it's all in the talking.
    Ziegler W; Ackermann H
    Folia Phoniatr Logop; 2013; 65(2):55-67. PubMed ID: 23942013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and perceptual features of dysarthria in Moebius syndrome: directions for treatment.
    Murdoch BE; Johnson SM; Theodoros DG
    Pediatr Rehabil; 1997; 1(2):83-97. PubMed ID: 9689243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech-language pathology and dysphagia in multiple sclerosis.
    Merson RM; Rolnick MI
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):631-41. PubMed ID: 9894114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor speech impairment following traumatic brain injury in childhood: a physiological and perceptual analysis of one case.
    Theodoros DG; Shrapnel N; Murdoch BE
    Pediatr Rehabil; 1998; 2(3):107-22. PubMed ID: 9864744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of communication: dysarthria.
    Enderby P
    Handb Clin Neurol; 2013; 110():273-81. PubMed ID: 23312647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of smooth speech on the speech production of an individual with ataxic dysarthria.
    Stocks R; Dacakis G; Phyland D; Rose M
    Brain Inj; 2009 Sep; 23(10):820-9. PubMed ID: 19697171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysarthria and aphagia: a case study of neuromuscular treatment.
    Harris B; Murry T
    Arch Phys Med Rehabil; 1984 Jul; 65(7):408-12. PubMed ID: 6743001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between speech and swallowing disorders in patients with neuromuscular disease.
    Nishio M; Niimi S
    Folia Phoniatr Logop; 2004; 56(5):291-304. PubMed ID: 15375331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological aspects and neurological speech therapy: target of dysphony, dysarthria and dysphagia.
    Megna M; Cortese R; Dellomonaco A; Bellomo RG; Salonna I; Cristella G; Ranieri M
    Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):29S-33S. PubMed ID: 22652159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland.
    Conway A; Walshe M
    Int J Lang Commun Disord; 2015; 50(3):374-88. PubMed ID: 25652223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysarthria in children with cerebellar or brainstem tumors.
    van Mourik M; Catsman-Berrevoets CE; Yousef-Bak E; Paquier PF; van Dongen HR
    Pediatr Neurol; 1998 May; 18(5):411-4. PubMed ID: 9650681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Voice, Speech, and Swallowing Disorders in Oromandibular Dystonia.
    Kreisler A; Verpraet AC; Veit S; Pennel-Ployart O; Béhal H; Duhamel A; Destée A
    J Speech Lang Hear Res; 2016 Oct; 59(5):940-949. PubMed ID: 27617622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood Dysarthria: Auditory-Perceptual Profiles Against the Background of Typical Speech Motor Development.
    Schölderle T; Haas E; Ziegler W
    J Speech Lang Hear Res; 2022 Jun; 65(6):2114-2127. PubMed ID: 35537116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.